ViaCyte released encouraging data just now on a patient with implanted stem cell-derived pancreas-like device whose diabetes improved. You can read more about this in the Endpoints piece that I linked to in the previous sentence. Stem cells for diabetes; the ViaCyte update The idea of stem cells for diabetes has been more on my […]
Quick reaction to milestone ViaCyte data on a diabetes patient Read More »
When it comes to stem cells on Twitter and other social media, who do you follow now? Why them? Who are the top stem cell and regenerative medicine influencers to follow on Twitter and elsewhere in 2021? Stem cells on Twitter: great content amongst the noise Terrapin asked this kind of broad question to some
50 influencers on stem cells on Twitter to follow in 2021 Read More »
The title of a new article in Stem Cells and Development may seem audacious to those unfamiliar with the plight of the northern white rhino and the promise of induced pluripotent stem cells. But “Rewinding Extinction in the Northern White Rhinoceros” may turn out to be accurate for what a genetically diverse stem cell bank
Will Stem Cells Save the Northern White Rhino? Read More »
I’m playing catch-up on some reading given how busy I’ve been and this includes a groundbreaking NEJM pub on CRISPR for Sickle Cell and Thalassemia. CRISPR for Sickle Cell From December, here’s the key paper in the NEJM: CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. There’s a lot to like about this clinical
Recommended reads: CRISPR for Sickle Cell, Parkinson’s, & more Read More »
The Niche has had many authors over the years, focusing on expertise in the biomedical arena and in particular related to stem cells. I’ve invited many authorities in particular areas to write posts. Over the years I’ve written probably 99+% of the posts here on The Niche, but we’ve also had some great guest authors
Authors on The Niche Read More »
Back in 2013, a half dozen years ago, I went out on a limb and made predictions for the stem cell field for 2020. These are different than my yearly predictions for the coming year (for instance, you can see my predictions made in 2018 for this year of 2019 here). As to my 2013
7-Year Glitch? Updates on my overly optimistic 2013 stem cell predictions for 2020 Read More »
We’re seeing more muddy waters in the stem cell universe. A chiropractic stem cell and alternative medicine clinic has popped up calling itself, of all things, CIRM. On another front, an already controversial docuseries set to air tomorrow combines interviews with prominent academic stem cell scientists and unproven stem cell clinic folks, muddying the waters.
Muddy waters: stem cell clinic calls itself CIRM & docuseries sparks controversy Read More »
Who are the top stem cell and regenerative medicine influencers to follow on Twitter and elsewhere in 2019? Terrapin asked this kind of broad question to some within our community about 5 years ago and came up with a Top 50 list of stem cell influencers, which I like to joke I was “at the top
50 stem cell influencers on Twitter to follow in 2019 Read More »
In Parkinson’s Disease patients develop neurological dysfunction as they lose a special kind of brain cell called dopaminergic (or dopamine) neurons. While a number of different approaches to this disease have been studied for decades, nothing has proven particularly successful in slowing its progression. As a result there has been a big need for novel thinking
Hope on Parkinson’s front: Japan IPSC trial 1st patient Read More »
By Jeanne Loring Stem cells boldly go… Last week at the New York Stem Cell Foundation (NYSCF) conference at Rockefeller University in New York City, we announced our collaborative project to study the effects of microgravity on neurons derived from patient-specific induced pluripotent stem cells. The press release is here. Susan Solomon, the CEO of
Stem Cells in Space Read More »